CIK 0001846253 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 49 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Love Steven Director | Option exercise · Restricted Stock Units | −20,000 | 13,334 | ||
| 2026-06-17 | Love Steven Director | Grant or award · Restricted Stock Units | +20,000 | 33,334 | ||
| 2026-06-17 | Love Steven Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-06-17 | HIGGINS JOHN L Director | Option exercise | +20,000 | 2,962,320 | ||
| 2026-06-17 | HIGGINS JOHN L Director | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2026-06-17 | HIGGINS JOHN L Director | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2026-06-17 | HIGGINS JOHN L Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-04-21 | Crouse Steven C. Director | Option exercise | +13,333 | 13,333 | ||
| 2026-04-21 | Crouse Steven C. Director | Option exercise · Restricted Stock Units | −13,333 | 46,667 | ||
| 2026-04-21 | Gotwals Philip J Director | Option exercise | +13,333 | 13,333 | ||
| 2026-04-21 | Gotwals Philip J Director | Option exercise · Restricted Stock Units | −13,333 | 46,667 | ||
| 2026-04-07 | FOEHR MATTHEW W President and CEO | Option exercise | +36,459 | 4,439,736 | ||
| 2026-04-07 | FOEHR MATTHEW W President and CEO | Sale | −19,244 | $1.49 | $29K | 4,420,492 |
| 2026-04-07 | FOEHR MATTHEW W President and CEO | Option exercise · Restricted Stock Units | −36,459 | 309,376 | ||
| 2026-04-07 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | +13,542 | 268,396 | ||
| 2026-04-07 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | −6,913 | $1.49 | $10K | 261,483 |
| 2026-04-07 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise · Restricted Stock Units | −13,542 | 111,042 | ||
| 2026-04-07 | Berkman Charles S Chief Legal Officer | Option exercise | +13,542 | 406,242 | ||
| 2026-04-07 | Berkman Charles S Chief Legal Officer | Sale | −7,157 | $1.49 | $11K | 399,085 |
| 2026-04-07 | Berkman Charles S Chief Legal Officer | Option exercise · Restricted Stock Units | −13,542 | 111,042 |
Page 2 of 15 · 285 trades